Sonoma Pharmaceuticals, Inc. - What You Need to Know

Thinking about investing in Sonoma Pharmaceuticals? It is exciting to get in on the ground floor, but before you invest, let’s break down what this company does in plain English.

1. What does this company actually do?

Sonoma uses science to improve skin and wound care. For over 20 years, they have perfected technology based on hypochlorous acid (HOCl). This substance mimics how our bodies naturally fight germs.

Instead of harsh chemicals or antibiotics, they use this solution to heal wounds, treat skin conditions like acne, and support eye care. They are not just a lab project; they hold 22 FDA clearances and sell products in over 55 countries. Their business relies on the proprietary Microcyn® technology platform, which creates non-toxic, biocompatible products for dermatology, wound care, and animal health.

2. What is this specific offering?

As of April 2026, Sonoma is raising about $5 million by selling "units" to investors. Each unit includes:

• One share of common stock.
• Warrants: You receive two types of "coupons":
  • Common Warrants: These let you buy more stock later at a set price for up to five years.
  • Pre-Funded Warrants: These are "pre-paid" coupons that let you buy shares for a tiny price of $0.0001 each. These help investors who would otherwise hit ownership limits.
• Important Note: These warrants are not listed on any stock exchange. Because there is no public market for them, you may find it very difficult to sell the warrants themselves.

3. How do they make money?

They sell prescription and over-the-counter items for dermatology, wound care, and animal health, both directly and through international partners. The company expects to net $4.48 million from this offering. They plan to use this cash for general corporate purposes, including research, clinical trials, marketing, and daily operations.

4. What are the main risks?

Investing in small medical companies is high-stakes. Keep these risks in mind:

• Dilution: You will experience "immediate dilution." You are paying more per share than the company’s current net value per share. Also, when these warrants are exercised, the company issues more shares, which reduces your ownership percentage.
• Control: The board can issue "blank check" preferred stock without asking you. This could change your voting power, prioritize other investors over you, or make it harder for the company to be bought out.
• Volatility: The stock price can swing wildly. Because the company is small, news or market sentiment can cause big price jumps or drops.
• Ownership Limits: The warrants include an ownership cap. You generally cannot exercise them if it would make you own more than 4.99% or 9.99% of the company.

5. The Details

• Ticker Symbol: SNOA (Nasdaq)
• Dividends: None. The company keeps all earnings to fund its growth.

A final piece of advice: This is a small-cap medical stock, so it can be very volatile. Never invest money you cannot afford to lose. Before you make a decision, take a moment to search for the company’s official "Prospectus" on the SEC’s EDGAR website—it contains the full legal breakdown of these risks and the company's financial health.